Sodium Bicarbonate and N-Acetylcysteine tested for the prevention of serious adverse outcomes
Educational information
This 3-minute education provides a summary of just presented scientific data, recorded during the AHA 2017 congress. The objective is to provide a brief commentary and potential implications of these findings.
Faculty
Dr. Steven Weisbord is a nephrologist at the VA Pittsburgh Healthcare System and Associate Professor of Medicine and Clinical and Translational Science at the Renal-Electrolyte Division at the University of Pittsburgh School of Medicine
Share this page with your colleagues and friends: